TINN2 is a European research network (Collaborative Project) supported by the European Commission under the Health Cooperation Work Programme of the 7 th Framework Programme.

News & Events

 

TINN European Survey on the Use of Antibiotics in NICUs

The survey results are now available and the published article has been published.

Please click here to consult it.

 

MANY THANKS to all the Neonatal Intensive Care Units that dedicated their time to partipate in the TINN2 survey.

 

Consortium final meeting on 8th October 2015, in Paris, France

The official event of the TINN2 FP7 European Research Project was organised by Inserm-Transfert on 8th October 2015 in Paris (France).

This meeting gathered together all TINN2 partners for presenting and discussing the latest progresses within TINN2 activities, a project on preclinical studies and paediatric investigation plans for children, under the coordination of the French National Institute of Health and Medical Research (Inserm).

European Congress of Clinical Microbiology and Infectious Diseases, London, United Kingdom 31st to 4th April 2012

 

TINN2 Project was presented on Poster at the ECCMID congress in London, United Kingdom.

Brochure PDF :

Inserm Transfert SA

Inserm Transfert SA, a subsidiary of the French Institute for Health and Medical Research (Inserm), is the public limited SME Company responsible for the management of the TINN2 consortium and for the co-ordination of activities on programme-related transversal issues. The company possesses extensive expertise in two core areas: i) Intellectual property management, technology transfer and exploitation of research results; ii) specific tools and gold standard methods for supporting Inserm and non-Inserm (European) scientists in their international project preparation and management (ex: 24 FP6 EC-funded projects are currently managed by the company). Inserm Transfert SA has a strong expertise in the financial rules of the FP6 program and all related contractual aspects and can anticipate and solve quickly any kind of emerging problems within large consortia. It has already established management links with almost all research organisations in Europe.

 

Dr Natacha Edme has been working at Inserm Transfert SA since February 2005 in the management of five FP6 & FP7 projects in the fields of anti-infectious drugs (VIRGIL, TINN and TINN2) and of diagnostic tests for infectious neglected diseases in Africa and Asia (TRYLEIDIAG and NIDIAG). To fulfil her management mission, Dr. Edme takes advantage of her former complementary experiences both in research (Ph.D. and Postdoctoral position in cancer research / lecturer in microbiology) and in research administration at Human Resources Department of Inserm, as promoter for researcher mobility. 

Back to the list of institutions